Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. CD151 - Wikipedia
CD151 - Wikipedia
From Wikipedia, the free encyclopedia
Protein-coding gene in humans

CD151
Identifiers
AliasesCD151, GP27, MER2, PETA-3, RAPH, SFA1, TSPAN24, CD151 molecule (Raph blood group), EBS7
External IDsOMIM: 602243; MGI: 1096360; HomoloGene: 20916; GeneCards: CD151; OMA:CD151 - orthologs
Gene location (Human)
Chromosome 11 (human)
Chr.Chromosome 11 (human)[1]
Chromosome 11 (human)
Genomic location for CD151
Genomic location for CD151
Band11p15.5Start832,887 bp[1]
End839,831 bp[1]
Gene location (Mouse)
Chromosome 7 (mouse)
Chr.Chromosome 7 (mouse)[2]
Chromosome 7 (mouse)
Genomic location for CD151
Genomic location for CD151
Band7 F5|7 86.82 cMStart141,047,305 bp[2]
End141,051,386 bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • Descending thoracic aorta

  • ascending aorta

  • right coronary artery

  • left coronary artery

  • popliteal artery

  • tibial arteries

  • stromal cell of endometrium

  • apex of heart

  • body of pancreas

  • upper lobe of left lung
Top expressed in
  • endothelial cell of lymphatic vessel

  • medullary collecting duct

  • Paneth cell

  • renal corpuscle

  • iris

  • tunica media of zone of aorta

  • carotid body

  • tunica adventitia of aorta

  • ciliary body

  • decidua
More reference expression data
BioGPS
More reference expression data
Gene ontology
Molecular function
  • integrin binding
  • protein binding
Cellular component
  • cytosol
  • membrane
  • focal adhesion
  • basement membrane
  • integral component of membrane
  • integral component of plasma membrane
  • plasma membrane
  • cell surface
Biological process
  • cell adhesion
  • cell surface receptor signaling pathway
  • hemidesmosome assembly
  • T cell proliferation
  • cell migration
  • positive regulation of cell migration
  • wound healing, spreading of cells
  • positive regulation of endocytosis
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

977

12476

Ensembl

ENSG00000177697

ENSMUSG00000025510

UniProt

P48509
Q6ZNZ0

O35566

RefSeq (mRNA)

NM_139030
NM_001039490
NM_004357
NM_139029

NM_001111049
NM_001111050
NM_009842

RefSeq (protein)
NP_001034579
NP_004348
NP_620598
NP_620599
NP_001034579.1

NP_004348.2
NP_620598.1
NP_620599.1

NP_001104519
NP_001104520
NP_033972

Location (UCSC)Chr 11: 0.83 – 0.84 MbChr 7: 141.05 – 141.05 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

CD151 molecule (Raph blood group), also known as CD151 (Cluster of Differentiation 151), is a human gene.[5]

Function

[edit]

The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein that is known to complex with integrins and other transmembrane 4 superfamily proteins. It is involved in cellular processes including cell adhesion and may regulate integrin trafficking and/or function. This protein enhances cell motility, invasion and metastasis of cancer cells. Multiple alternatively spliced transcript variants that encode the same protein have been described for this gene.[5] Abnormalities in CD151 have been implicated in a form of epidermolysis bullosa.[6][7]

Interactions

[edit]
Fibrosarcoma cells, reportedly stained with an antibody binding to CD151 (green) and a dye for the nucleus (blue).

CD151 has been shown to interact with CD46.[8]

See also

[edit]
  • Cluster of differentiation
  • Tetraspanin

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000177697 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000025510 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b "Entrez Gene: CD151 CD151 molecule (Raph blood group)".
  6. ^ Bardhan A, Bruckner-Tuderman L, Chapple IL, Fine JD, Harper N, Has C, et al. (September 2020). "Epidermolysis bullosa". Nature Reviews. Disease Primers. 6 (1) 78. doi:10.1038/s41572-020-0210-0. PMID 32973163. S2CID 221861310.
  7. ^ Vahidnezhad H, Youssefian L, Saeidian AH, Mahmoudi H, Touati A, Abiri M, et al. (March 2018). "Recessive mutation in tetraspanin CD151 causes Kindler syndrome-like epidermolysis bullosa with multi-systemic manifestations including nephropathy". Matrix Biology. 66: 22–33. doi:10.1016/j.matbio.2017.11.003. hdl:11573/1182681. PMID 29138120. S2CID 3812225.
  8. ^ Lozahic S, Christiansen D, Manié S, Gerlier D, Billard M, Boucheix C, et al. (March 2000). "CD46 (membrane cofactor protein) associates with multiple beta1 integrins and tetraspans". European Journal of Immunology. 30 (3): 900–907. doi:10.1002/1521-4141(200003)30:3<900::AID-IMMU900>3.0.CO;2-X. PMID 10741407.

Further reading

[edit]
  • Berditchevski F (December 2001). "Complexes of tetraspanins with integrins: more than meets the eye". Journal of Cell Science. 114 (Pt 23): 4143–4151. doi:10.1242/jcs.114.23.4143. PMID 11739647.
  • Ashman LK (2003). "CD151". Journal of Biological Regulators and Homeostatic Agents. 16 (3): 223–226. PMID 12456024.
  • Ashman LK, Aylett GW, Mehrabani PA, Bendall LJ, Niutta S, Cambareri AC, et al. (October 1991). "The murine monoclonal antibody, 14A2.H1, identifies a novel platelet surface antigen". British Journal of Haematology. 79 (2): 263–270. doi:10.1111/j.1365-2141.1991.tb04531.x. PMID 1958484. S2CID 6682391.
  • Fitter S, Tetaz TJ, Berndt MC, Ashman LK (August 1995). "Molecular cloning of cDNA encoding a novel platelet-endothelial cell tetra-span antigen, PETA-3". Blood. 86 (4): 1348–1355. doi:10.1182/blood.V86.4.1348.bloodjournal8641348. hdl:2440/103301. PMID 7632941.
  • Maruyama K, Sugano S (January 1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–174. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
  • Hasegawa H, Utsunomiya Y, Kishimoto K, Yanagisawa K, Fujita S (May 1996). "SFA-1, a novel cellular gene induced by human T-cell leukemia virus type 1, is a member of the transmembrane 4 superfamily". Journal of Virology. 70 (5): 3258–3263. doi:10.1128/JVI.70.5.3258-3263.1996. PMC 190191. PMID 8627808.
  • Hasegawa H, Kishimoto K, Yanagisawa K, Terasaki H, Shimadzu M, Fujita S (February 1997). "Assignment of SFA-1 (PETA-3), a member of the transmembrane 4 superfamily, to human chromosome 11p15.5 by fluorescence in situ hybridization". Genomics. 40 (1): 193–196. doi:10.1006/geno.1996.4563. PMID 9070943.
  • Sincock PM, Mayrhofer G, Ashman LK (April 1997). "Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: comparison with CD9, CD63, and alpha5beta1 integrin". The Journal of Histochemistry and Cytochemistry. 45 (4): 515–525. doi:10.1177/002215549704500404. PMID 9111230.
  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (October 1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–156. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
  • Fitter S, Seldin MF, Ashman LK (May 1998). "Characterisation of the mouse homologue of CD151 (PETA-3/SFA-1); genomic structure, chromosomal localisation and identification of 2 novel splice forms". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1398 (1): 75–85. doi:10.1016/S0167-4781(98)00034-7. PMID 9602068.
  • Sincock PM, Fitter S, Parton RG, Berndt MC, Gamble JR, Ashman LK (March 1999). "PETA-3/CD151, a member of the transmembrane 4 superfamily, is localised to the plasma membrane and endocytic system of endothelial cells, associates with multiple integrins and modulates cell function". Journal of Cell Science. 112 ( Pt 6) (6): 833–844. doi:10.1242/jcs.112.6.833. hdl:2440/8940. PMID 10036233.
  • Serru V, Le Naour F, Billard M, Azorsa DO, Lanza F, Boucheix C, et al. (May 1999). "Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions". The Biochemical Journal. 340 ( Pt 1) (Pt 1): 103–111. doi:10.1042/0264-6021:3400103. PMC 1220227. PMID 10229664.
  • Testa JE, Brooks PC, Lin JM, Quigley JP (August 1999). "Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis". Cancer Research. 59 (15): 3812–3820. PMID 10447000.
  • Sterk LM, Geuijen CA, Oomen LC, Calafat J, Janssen H, Sonnenberg A (May 2000). "The tetraspan molecule CD151, a novel constituent of hemidesmosomes, associates with the integrin alpha6beta4 and may regulate the spatial organization of hemidesmosomes". The Journal of Cell Biology. 149 (4): 969–982. doi:10.1083/jcb.149.4.969. PMC 2174566. PMID 10811835.
  • Whittock NV, McLean WH (February 2001). "Genomic organization, amplification, fine mapping, and intragenic polymorphisms of the human hemidesmosomal tetraspanin CD151 gene". Biochemical and Biophysical Research Communications. 281 (2): 425–430. Bibcode:2001BBRC..281..425W. doi:10.1006/bbrc.2001.4384. PMID 11181065.
  • Charrin S, Le Naour F, Oualid M, Billard M, Faure G, Hanash SM, et al. (April 2001). "The major CD9 and CD81 molecular partner. Identification and characterization of the complexes". The Journal of Biological Chemistry. 276 (17): 14329–14337. doi:10.1074/jbc.M011297200. PMID 11278880.
  • Suzuki Y, Tsunoda T, Sese J, Taira H, Mizushima-Sugano J, Hata H, et al. (May 2001). "Identification and characterization of the potential promoter regions of 1031 kinds of human genes". Genome Research. 11 (5): 677–684. doi:10.1101/gr.gr-1640r. PMC 311086. PMID 11337467.
  • Kohno M, Hasegawa H, Miyake M, Yamamoto T, Fujita S (January 2002). "CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase". International Journal of Cancer. 97 (3): 336–343. doi:10.1002/ijc.1605. PMID 11774285. S2CID 46569418.
  • Zhang XA, Kazarov AR, Yang X, Bontrager AL, Stipp CS, Hemler ME (January 2002). "Function of the tetraspanin CD151-alpha6beta1 integrin complex during cellular morphogenesis". Molecular Biology of the Cell. 13 (1): 1–11. doi:10.1091/mbc.01-10-0481. PMC 65068. PMID 11809818.

External links

[edit]
  • Raph blood group system in the BGMUT blood group antigen gene mutation database
  • Human CD151 genome location and CD151 gene details page in the UCSC Genome Browser.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

  • v
  • t
  • e
Proteins: clusters of differentiation (see also list of human clusters of differentiation)
1–50
  • CD1
    • a-c
    • 1A
    • 1B
    • 1D
    • 1E
  • CD2
  • CD3
    • γ
    • δ
    • ε
  • CD4
  • CD5
  • CD6
  • CD7
  • CD8
    • a
  • CD9
  • CD10
  • CD11
    • a
    • b
    • c
    • d
  • CD13
  • CD14
  • CD15
  • CD16
    • A
    • B
  • CD18
  • CD19
  • CD20
  • CD21
  • CD22
  • CD23
  • CD24
  • CD25
  • CD26
  • CD27
  • CD28
  • CD29
  • CD30
  • CD31
  • CD32
    • A
    • B
  • CD33
  • CD34
  • CD35
  • CD36
  • CD37
  • CD38
  • CD39
  • CD40
  • CD41
  • CD42
    • a
    • b
    • c
    • d
  • CD43
  • CD44
  • CD45
  • CD46
  • CD47
  • CD48
  • CD49
    • a
    • b
    • c
    • d
    • e
    • f
  • CD50
51–100
  • CD51
  • CD52
  • CD53
  • CD54
  • CD55
  • CD56
  • CD57
  • CD58
  • CD59
  • CD61
  • CD62
    • E
    • L
    • P
  • CD63
  • CD64
    • A
    • B
    • C
  • CD66
    • a
    • b
    • c
    • d
    • e
    • f
  • CD68
  • CD69
  • CD70
  • CD71
  • CD72
  • CD73
  • CD74
  • CD78
  • CD79
    • a
    • b
  • CD80
  • CD81
  • CD82
  • CD83
  • CD84
  • CD85
    • a
    • d
    • e
    • h
    • j
    • k
  • CD86
  • CD87
  • CD88
  • CD89
  • CD90
  • CD91 - CD92
  • CD93
  • CD94
  • CD95
  • CD96
  • CD97
  • CD98
  • CD99
  • CD100
101–150
  • CD101
  • CD102
  • CD103
  • CD104
  • CD105
  • CD106
  • CD107
    • a
    • b
  • CD108
  • CD109
  • CD110
  • CD111
  • CD112
  • CD113
  • CD114
  • CD115
  • CD116
  • CD117
  • CD118
  • CD119
  • CD120
    • a
    • b
  • CD121
    • a
    • b
  • CD122
  • CD123
  • CD124
  • CD125
  • CD126
  • CD127
  • CD129
  • CD130
  • CD131
  • CD132
  • CD133
  • CD134
  • CD135
  • CD136
  • CD137
  • CD138
  • CD140b
  • CD141
  • CD142
  • CD143
  • CD144
  • CD146
  • CD147
  • CD148
  • CD150
151–200
  • CD151
  • CD152
  • CD153
  • CD154
  • CD155
  • CD156
    • a
    • b
    • c
  • CD157
  • CD158 (a
  • d
  • e
  • i
  • k)
  • CD159
    • a
    • c
  • CD160
  • CD161
  • CD162
  • CD163
  • CD164
  • CD166
  • CD167
    • a
    • b
  • CD168
  • CD169
  • CD170
  • CD171
  • CD172
    • a
    • b
    • g
  • CD174
  • CD177
  • CD178
  • CD179
    • a
    • b
  • CD180
  • CD181
  • CD182
  • CD183
  • CD184
  • CD185
  • CD186
  • CD191
  • CD192
  • CD193
  • CD194
  • CD195
  • CD196
  • CD197
  • CDw198
  • CDw199
  • CD200
201–250
  • CD201
  • CD202b
  • CD204
  • CD205
  • CD206
  • CD207
  • CD208
  • CD209
  • CDw210
    • a
    • b
  • CD212
  • CD213a
    • 1
    • 2
  • CD217
  • CD218 (a
  • b)
  • CD220
  • CD221
  • CD222
  • CD223
  • CD224
  • CD225
  • CD226
  • CD227
  • CD228
  • CD229
  • CD230
  • CD233
  • CD234
  • CD235
    • a
    • b
  • CD236
  • CD238
  • CD239
  • CD240CE
  • CD240D
  • CD241
  • CD243
  • CD244
  • CD246
  • CD247 - CD248
  • CD249
251–300
  • CD252
  • CD253
  • CD254
  • CD256
  • CD257
  • CD258
  • CD261
  • CD262
  • CD263
  • CD264
  • CD265
  • CD266
  • CD267
  • CD268
  • CD269
  • CD271
  • CD272
  • CD273
  • CD274
  • CD275
  • CD276
  • CD278
  • CD279
  • CD280
  • CD281
  • CD282
  • CD283
  • CD284
  • CD286
  • CD288
  • CD289
  • CD290
  • CD292
  • CDw293
  • CD294
  • CD295
  • CD297
  • CD298
  • CD299
301–350
  • CD300A
  • CD301
  • CD302
  • CD303
  • CD304
  • CD305
  • CD306
  • CD307
  • CD309
  • CD312
  • CD314
  • CD315
  • CD316
  • CD317
  • CD318
  • CD320
  • CD321
  • CD322
  • CD324
  • CD325
  • CD326
  • CD327
  • CD328
  • CD329
  • CD331
  • CD332
  • CD333
  • CD334
  • CD335
  • CD336
  • CD337
  • CD338
  • CD339
  • CD340
  • CD344
  • CD349
  • CD350
  • v
  • t
  • e
Protein: cell membrane proteins (other than Cell surface receptor, enzymes, and cytoskeleton)
Arrestin
  • SAG
  • ARRB1
  • ARRB2
  • ARR3
Membrane-spanning 4A
  • MS4A1
  • MS4A2
  • MS4A3
  • MS4A4A
  • MS4A4E
  • MS4A5
  • MS4A6A
  • MS4A6E
  • MS4A7
  • MS4A8B
  • MS4A9
  • MS4A10
  • MS4A12
  • MS4A13
  • MS4A14
  • MS4A15
  • MS4A18
Myelin
  • Myelin basic protein
    • PMP2
  • Myelin proteolipid protein
    • PLP1
  • Myelin oligodendrocyte glycoprotein
  • Myelin-associated glycoprotein
  • Myelin protein zero
Pulmonary surfactant
  • Pulmonary surfactant-associated protein B
  • Pulmonary surfactant-associated protein C
Tetraspanin
  • TSPAN1
  • TSPAN2
  • TSPAN3
  • TSPAN4
  • TSPAN5
  • TSPAN6
  • TSPAN7
  • TSPAN8
  • TSPAN9
  • TSPAN10
  • TSPAN11
  • TSPAN12
  • TSPAN13
  • TSPAN14
  • TSPAN15
  • TSPAN16
  • TSPAN17
  • TSPAN18
  • TSPAN19
  • TSPAN20
  • TSPAN21
  • TSPAN22
  • TSPAN23
  • TSPAN24
  • TSPAN25
  • TSPAN26
  • TSPAN27
  • TSPAN28
  • TSPAN29
  • TSPAN30
  • TSPAN31
  • TSPAN32
  • TSPAN33
  • TSPAN34
Other/ungrouped
  • Calnexin
  • LDL-receptor-related protein-associated protein
  • Neurofibromin 2
  • Presenilin
    • PSEN1
    • PSEN2
  • HFE
  • Phospholipid transfer proteins
  • Dysferlin
  • STRC
  • OTOF
see also other cell membrane protein disorders
Stub icon

This membrane protein–related article is a stub. You can help Wikipedia by adding missing information.

  • v
  • t
  • e
Retrieved from "https://teknopedia.ac.id/w/index.php?title=CD151&oldid=1300831930"
Categories:
  • Genes on human chromosome 11
  • Clusters of differentiation
  • Membrane protein stubs
  • Blood antigen systems
  • Transfusion medicine
Hidden categories:
  • Articles with short description
  • Short description is different from Wikidata
  • CS1: long volume value
  • Wikipedia articles incorporating text from the United States National Library of Medicine
  • All stub articles

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id